Keywords: استنت (ها); drug-eluting balloon; in-stent restenosis; paclitaxel-coated balloon; percutaneous coronary intervention; target lesion failure; BSR; drug-eluting balloon-to-stent ratio; CI; confidence interval; DEB; drug-eluting balloon; DES; drug-eluting stent(s)
مقالات ISI استنت (ها) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: استنت (ها); drug-eluting stent(s); percutaneous coronary intervention; platelet reactivity; stroke; ARU; aspirin reaction unit(s); CI; confidence interval; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); HR; hazard ratio; HS; hemorrhagic stroke; IS; isc
Keywords: استنت (ها); adventitia; dexamethasone; drug delivery; peripheral artery disease; restenosis; ABI; ankle-brachial index; ADD; adventitial drug delivery; ATX; atherectomy; CD-TLR; clinically driven target lesion revascularization; DCB; drug-coated balloon(s); DES; drug
Keywords: استنت (ها); DES; drug-eluting stent(s); HbA1c; impaired glucose tolerance; OGTT; oral glucose tolerance testing; PCI; percutaneous coronary intervention; silent diabetes; DES; drug-eluting stent(s); DM; diabetes mellitus; FPG; fasting plasma glucose; IFG; impaired f
Keywords: استنت (ها); bifurcation lesion; left main coronary artery; percutaneous coronary intervention; ACS; acute coronary syndrome(s); CABG; coronary artery bypass; C-DES; current-generation drug-eluting stent(s); CI; confidence interval; CKD; chronic kidney disease; DES; d
Keywords: استنت (ها); new-generation drug-eluting stents; patient-level pooled analysis of women; percutaneous coronary intervention; stent length per lesion; stent length per patient; CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); HR; ha
Keywords: استنت (ها); biodegradable polymers; bioresorbable vascular scaffold; bleeding; drug-eluting stent; percutaneous coronary intervention; stent restenosis; stent thrombosis; 1G-DES; first-generation drug-eluting stent(s); 2G-DES; second-generation drug-eluting stent(s);
Keywords: استنت (ها); chronic total occlusion; drug-eluting stent(s); full metal jacket; outcome; CTO; chronic total occlusion; DES; drug-eluting stent(s); FMJ; full metal jacket; MI; myocardial infarction; PCI; percutaneous coronary intervention; TLF; target lesion failure;
Keywords: استنت (ها); AMI; acute myocardial infarction; BMS; bare-metal stent(s); DES; drug-eluting stent(s); FDA; Food and Drug Administration; PCI; percutaneous coronary intervention;
Keywords: استنت (ها); chronic total occlusion; collateral circulation; coronary physiology; prognosis; ATO; acute coronary syndrome with total or nearly total occlusion; CPI; collateral pressure index; CTO; chronic total coronary occlusion; DES; drug-eluting stent(s); FFRcor;
Keywords: استنت (ها); bioresorbable vascular scaffolds; complex coronary lesions; long coronary lesions; vascular reparative therapy; BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold(s); CI; confidence interval; DES; drug-eluting stent(s); HR; hazard ratio; MI; m
Keywords: استنت (ها); drug-coated balloon; femoropopliteal artery; in-stent restenosis; paclitaxel; peripheral artery disease; ABI; ankle-brachial index; CD; clinically driven; DCB; drug-coated balloon; DES; drug-eluting stent(s); DUS; duplex ultrasonography; ISR; in-stent res
Keywords: استنت (ها); complex lesions; dual antiplatelet therapy; dual antiplatelet therapy score; percutaneous coronary intervention; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MACCE; major adverse cardiovascular and cerebrovascular
Keywords: استنت (ها); biodegradable polymer; drug-eluting stent(s); durable polymer; meta-analysis; BMS; bare-metal stent(s); BP-DES; biodegradable polymer drug-eluting stent(s); CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); DP-DES; dura
Keywords: استنت (ها); drug-eluting stent(s); femoropopliteal lesion; in-stent restenosis; BNS; bare-metal nitinol stent(s); CI; confidence interval; CTO; chronic total occlusion; DES; drug-eluting stent(s); DM; diabetes mellitus; DUS; duplex ultrasonography; EEM; external elas
Keywords: استنت (ها); coronary artery bypass graft surgery; drug-eluting stents; multivessel coronary artery disease; CABG; coronary artery bypass graft; CAD; coronary artery disease; DES; drug-eluting stent(s); PCI; percutaneous coronary intervention;
Keywords: استنت (ها); 2-stent strategy; coronary bifurcation lesions; long-term clinical outcomes; percutaneous coronary intervention; CI; confidence interval; DES; drug-eluting stent(s); FKB; final kissing ballooning; HR; hazard ratio; IQR; interquartile range; MV; main vesse
Keywords: استنت (ها); drug-eluting stent(s); dual antiplatelet therapy; everolimus; stent thrombosisBMS, bare-metal stent(s); CI, confidence interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MACCE, major
Keywords: استنت (ها); bare-metal stent(s); bioresorbable vascular scaffolds; drug-eluting stent(s); percutaneous coronary intervention; stent thrombosisBMS, bare-metal stent(s); BP-BES, biodegradable polymer biolimus A9-eluting stent(s); BP-EES, biodegradable polymer everolimu
Keywords: استنت (ها); coronary disease; drug-coating balloon(s); drug-eluting stent(s); network meta-analysis; small coronary arteries%DS, percent diameter stenosis; BA, balloon angioplasty; BMS, bare-metal stent(s); CAD, coronary artery disease; DCB, drug-coated balloon(s); D
Keywords: استنت (ها); chronic kidney disease; drug-eluting stents; outcomes; women; CAD; coronary artery disease; CKD; chronic kidney disease; CrCl; creatinine clearance; DES; drug-eluting stent(s); MI; myocardial infarction; PCI; percutaneous coronary intervention; RCT; rando
Keywords: استنت (ها); coronary artery disease complexity; drug-eluting stent(s); percutaneous coronary intervention; SYNTAX scoreCABG, coronary artery bypass surgery; CAD, coronary artery disease; DES, drug-eluting stent(s); PCI, percutaneous coronary intervention
Keywords: استنت (ها); bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBES, biolimus-eluting stent(s); BMS, bare-metal stent(s); CI, credible interval; CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DES, drug-eluting stent(s); HR, hazard ratio
Keywords: استنت (ها); coronary artery bypass graft surgery; hybrid coronary artery revascularization; minimally invasive direct coronary artery bypass grafting; percutaneous coronary intervention; CABG; coronary artery bypass graft surgery; DES; drug-eluting stent(s); HCR; hyb
Keywords: استنت (ها); antiplatelet therapy; aspirin; coronary stent; drug-eluting stent; P2Y12 inhibitors; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); CAD; coronary artery disease; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); L-DAPT; long duratio
Keywords: استنت (ها); comparative effectiveness research; internal mammary-coronary artery anastomosis; outcomes research; CABG; coronary artery bypass graft surgery; CI; confidence interval; DES; drug-eluting stent(s); HR; hazard ratio; ICD9-CM; International Classification o
Keywords: استنت (ها); diabetes mellitus; drug-eluting stent(s); prognosis; ACC; American College of Cardiology; AHA; American Heart Association; BMS; bare-metal stent(s); CABG; coronary artery bypass grafting; CI; confidence interval; DES; drug-eluting stent(s); DM; diabetes m
Keywords: استنت (ها); bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBP, bioabsorbable polymers; BES, biolimus-eluting stent(s); CI, credible interval; CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DP, durable polymers; OR, odds ratio; PC-Z
Keywords: استنت (ها); coronary artery bypass graft; drug-eluting stent(s); meta-analysis; CABG; coronary artery bypass graft surgery; CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR; hazard ratio; LAD; left anterior descending; LM; lef
Keywords: استنت (ها); drug-eluting stent(s); intravascular ultrasound; left main coronary arteryDES, drug-eluting stent(s); IVUS, intravascular ultrasound; LM, left main coronary artery; MI, myocardial infarction; PCI, percutaneous coronary intervention; TLR, target lesion rev
Keywords: استنت (ها); drug-eluting stent(s); intravascular ultrasound; percutaneous coronary interventionBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; IVUS, intravascular ultrasound; MACE, major adverse cardiac events; MI, myo
Keywords: استنت (ها); acute coronary syndrome(s); bare-metal stent(s); drug-eluting stent(s); early stent thrombosis; histopathology; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); DES; drug-eluting stent(s); GEE; generalized estimating equation; IVUS; intravascula
Keywords: استنت (ها); drug-eluting stent(s); incomplete stent apposition; intravascular ultrasound; optical coherence tomography; percutaneous coronary intervention; stent malappositionBMS, bare-metal stent(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISA,
Keywords: استنت (ها); chronic coronary occlusion; stent reocclusion; CI; confidence interval(s); CTO; chronic total occlusion; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR; hazard ratio(s); OR; odds ratio(s); PCI; percutaneous coronary intervention; STAR; s
Keywords: استنت (ها); bare-metal stent(s); drug-eluting stent(s); stent thrombosis; ARC; Academic Research Consortium; BMS; bare-metal stent(s); CoCr-EES; cobalt-chromium everolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); FDA; Food and D
To EncourAGE Individualized Dual Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation
Keywords: استنت (ها); age; DAPT; drug-eluting stent(s); elderly; individualized therapy;
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis
Keywords: استنت (ها); bioresorbable scaffold; thrombosis; BRS; bioresorbable stent(s); BVS; Bioresorbable Vascular Scaffold; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MLD; minimum lumen diameter; QCA; quantitative coronary angiography; RVD; reference vessel
Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease
Keywords: استنت (ها); coronary artery disease; elective revascularization; follow-up; outcome; outpatient; ACE; angiotensin-converting enzyme; ARB; angiotensin receptor blocker; BMS; bare-metal stent(s); CABG; coronary artery bypass; CAD; coronary artery disease; CI; confidenc
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents
Keywords: استنت (ها); DES; long-term outcome; newer-generation drug-eluting stent(s); PCI; percutaneous coronary intervention; PROMUS Element everolimus-eluting stent(s); Resolute Integrity zotarolimus-eluting stent(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent
1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty
Keywords: استنت (ها); drug-eluting stent(s); Eluvia; long femoropopliteal lesions; paclitaxel; paclitaxel-eluting stent(s); peripheral arterial disease; CLTI; critical limb-threatening ischemia; DCB; drug-coated balloon; PES; paclitaxel-eluting stent(s); POBA; plain old balloo
New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome
Keywords: استنت (ها); fractional flow reserve; optical coherence tomography; restenosis; stent expansion; CM; conventional methodology; DES; drug-eluting stent(s); DoCE; device-oriented composite endpoint; FFR; fractional flow reserve; MEI; minimum expansion index; MSA; minima
Neoatherosclerosis 5 Years After Bioresorbable Vascular Scaffold Implantation
Keywords: استنت (ها); bioresorbable vascular scaffold; neoatherosclerosis; optical coherence tomography; AI; asymmetry index; BVS; bioresorbable vascular scaffold; CT; computed tomography; DES; drug-eluting stent(s); EI; eccentricity index; IVUS; intravascular ultrasound; NTG
Functionally Incomplete Re-Endothelialization of Stents and Neoatherosclerosisâ
Keywords: استنت (ها); biodegradable stent; cadherin; drug-eluting stent(s); endothelium; neoatherosclerosis; restenosis; stent thrombosis;
Bioresorbable Vascular Scaffolds Restenosis
Keywords: استنت (ها); bioresorbable vascular scaffold; drug-eluting stent(s); in-stent restenosis; optical coherence tomography;
DAPT Duration After Drug-Eluting Stent Implantation
Keywords: استنت (ها); bleeding event(s); drug-eluting stent(s); dual antiplatelet therapy; ischemic event(s); percutaneous coronary intervention;
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold
Keywords: استنت (ها); bioresorbable; coronary; scaffold; sirolimus-eluting; BRS; bioresorbable scaffold; DES; drug-eluting stent(s); ITT; intention-to-treat; LLL; late lumen loss; MACE; major adverse cardiac events(s); MI; myocardial infarction; MLD; minimum lumen diameter; P
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease
Keywords: استنت (ها); biodegradable polymer-coated stent(s); biolimus-eluting stent(s); everolimus-eluting stent(s); Nobori; Promus; Xience; BES; biolimus-eluting stent(s); BP-BES; biodegradable polymer biolimus-eluting stent(s); DES; drug-eluting stent(s); DP-EES; durable pol
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter
Keywords: استنت (ها); drug-eluting stent(s); percutaneous coronary intervention; reference vessel diameter; Resolute Onyx; restenosis; stent(s); zotarolimus; DES; drug-eluting stent(s); MACE; major adverse cardiac event(s); MI; myocardial infarction; PCI; percutaneous coronary
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: استنت (ها); restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent
Keywords: استنت (ها); drug-eluting stent; percutaneous coronary intervention; Resolute zotarolimus-eluting stent; stent thrombosis; ARC; Academic Research Consortium; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); MI; myocardial infarction; R-ZES; Resolute zotaro